September 11, 2023
Feature Articles
32
9
Experts weigh in on the latest advances and adoption trends.
September 11, 2023
Feature Articles
32
9
Approaching protocol design and operational planning with patient empathy.
September 08, 2023
Feature Articles
32
9
How advanced ePRO tools and approaches offer a path forward.
September 08, 2023
A Closing Thought
32
9
Steve Rosenberg, CEO of uMotif gives commentary on providing clinical trial patients with the best experience possible.
September 08, 2023
Clinical Trial Insights
32
9
Investigating more objectively measured 'structural' characteristics.
September 07, 2023
RBQM
32
9
Overall rate of significant KRI results for sites located in Ukraine has consistently risen since 2021.
September 07, 2023
Data Collection
32
9
Intended use must not replace the clinical decision-making process.
September 07, 2023
Q&A
32
9
In this Q&A, Rohit Nambisan, CEO of Lokavant, and Craig Lipset, founder of Clinical Innovation Partners and Lokavant advisory board member, brief ACT on what current uses of real-world data and analytics can mean to clinical trial execution.
September 06, 2023
From the Chairman
32
9
MJH Life Sciences, parent company of Applied Clinical Trials, continues to offer many forms of educational content to healthcare professionals.
September 06, 2023
From the Editor
32
9
Area of concern for oncology researchers must be addressed so trials can reflect a more accurate real-world population.
August 07, 2023
View from Brussels
32
9
With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.